A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

This study has been terminated.
(Roche has withdrawn support)
Sponsor:
Collaborators:
Aventis Pharmaceuticals
Roche Pharma AG
Information provided by (Responsible Party):
Nathan Bahary, MD, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177255
First received: September 12, 2005
Last updated: December 18, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)